Buy, Sell, Or Hold LLY Stock At $870?
Portfolio Pulse from
Eli Lilly (NYSE: LLY) reported better-than-expected fourth-quarter earnings with adjusted earnings per share of $5.32, surpassing the projected $4.95. However, revenue was slightly below expectations at $13.5 billion compared to the consensus estimate of $13.6 billion.
February 07, 2025 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Eli Lilly's Q4 earnings exceeded expectations with an EPS of $5.32, but revenue was slightly below estimates. This mixed result may lead to a neutral to slightly positive short-term impact on the stock price.
Eli Lilly's better-than-expected earnings per share is a positive indicator for investors, suggesting strong profitability. However, the slight revenue miss may temper enthusiasm. Overall, the positive earnings surprise is likely to have a slightly positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100